We are live on ! Find out more
NAMSW icon

NewAmsterdam Pharma Warrant
NAMSW

21 hedge funds and large institutions have $4.53M invested in NewAmsterdam Pharma Warrant in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+21
Holders Change %
–
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
–
Reduced
–
Closed
–
Calls
$65K
Puts
–
Net Calls
+$65K
Net Calls Change
+$65K

Top Buyers

Rank Fund Capital Flow
1
FLSM
Frazier Life Sciences Management
California
+$412K
2
RCM
RA Capital Management
Massachusetts
+$274K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$235K
4
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$123K
5
ETH
Exos TFP Holdings
New York
+$113K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$1.89M +$235K +285,105 New
EC
2
EcoR1 Capital
California
$727K +$54.9K +66,665 New
HCM
3
Highbridge Capital Management
New York
$564K – – –
FLSM
4
Frazier Life Sciences Management
California
$434K +$412K +500,333 New
RCM
5
RA Capital Management
Massachusetts
$289K +$274K +333,333 New
Ensign Peak Advisors
6
Ensign Peak Advisors
Utah
$120K +$123K +150,000 New
ETH
7
Exos TFP Holdings
New York
$119K +$113K +137,317 New
BCLSI
8
Bain Capital Life Sciences Investors
Massachusetts
$86K +$82.3K +100,000 New
DM
9
Deerfield Management
New York
$80.6K +$76.4K +92,787 New
CCA
10
Castle Creek Arbitrage
Colorado
$43K +$42.4K +51,520 New
PI
11
PEAK6 Investments
Illinois
$34.8K +$33K +40,033 New
WCMNY
12
Westchester Capital Management (New York)
New York
$25K +$25.7K +31,189 New
Walleye Capital
13
Walleye Capital
New York
$24.6K +$23.4K +28,388 New
HF
14
HRT Financial
New York
$24K +$25K +30,321 New
CC
15
Caxton Corporation
New Jersey
$17.8K +$17.6K +21,333 New
Walleye Trading
16
Walleye Trading
New York
$14.2K +$13.5K +16,356 New
LCM
17
Laurion Capital Management
New York
$13.3K +$13.7K +16,666 New
VI
18
Vestcor Inc
New Brunswick, Canada
$8K +$7.93K +9,632 New
DCM
19
Dupont Capital Management
Delaware
$6.67K +$6.86K +8,333 New
MTCM
20
Mint Tower Capital Management
Netherlands
$6K +$5.38K +6,533 New
WAM
21
Wolverine Asset Management
Illinois
$1.27K +$1.2K +1,462 New
UBS Group
22
UBS Group
Switzerland
$936 +$886 +1,076 New

NAMSW Hedge Fund Activity: Q4 2022 in Review

21 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in NewAmsterdam Pharma Warrant (NAMSW) for Q4 2022, worth a combined $4.53M.

Buyers outnumbered sellers: 21 funds opened new NAMSW positions and 0 closed out — a net gain of 21 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Frazier Life Sciences Management, opening a new position worth an estimated $412K.

  • 21 institutional investors held NewAmsterdam Pharma Warrant (NAMSW) as of Q4 2022, up from 0 in Q3 2022.
  • Funds reported $4.53M of NewAmsterdam Pharma Warrant stock for Q4 2022.
  • 21 funds opened new NewAmsterdam Pharma Warrant positions in Q4 2022 and 0 closed out, a net change of +21 holders.
  • The largest NewAmsterdam Pharma Warrant buyer in Q4 2022 was Frazier Life Sciences Management, an estimated $412K added.

Based on aggregated 13F filings for Q4 2022.